Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-01-27

FDA Approved: ZOLMITRIPTAN — Supplemental Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for zolmitriptan from Alembic Pharmaceuticals Inc. under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zolmitriptan (zolmitriptan)

Snippet

SUPPL AP for ZOLMITRIPTAN (ZOLMITRIPTAN)